160 related articles for article (PubMed ID: 9121114)
1. Thyroid-stimulating hormone promotes growth of thyroid carcinomas in transgenic mice with targeted expression of the ret/PTC1 oncogene.
Sagartz JE; Jhiang SM; Tong Q; Capen CC
Lab Invest; 1997 Mar; 76(3):307-18. PubMed ID: 9121114
[TBL] [Abstract][Full Text] [Related]
2. Thyroid carcinomas in RET/PTC transgenic mice.
Jhiang SM; Cho JY; Furminger TL; Sagartz JE; Tong Q; Capen CC; Mazzaferri EL
Recent Results Cancer Res; 1998; 154():265-70. PubMed ID: 10027006
[TBL] [Abstract][Full Text] [Related]
3. Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice.
Santoro M; Chiappetta G; Cerrato A; Salvatore D; Zhang L; Manzo G; Picone A; Portella G; Santelli G; Vecchio G; Fusco A
Oncogene; 1996 Apr; 12(8):1821-6. PubMed ID: 8622903
[TBL] [Abstract][Full Text] [Related]
4. The RET/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids.
Powell DJ; Russell J; Nibu K; Li G; Rhee E; Liao M; Goldstein M; Keane WM; Santoro M; Fusco A; Rothstein JL
Cancer Res; 1998 Dec; 58(23):5523-8. PubMed ID: 9850089
[TBL] [Abstract][Full Text] [Related]
5. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas.
Jhiang SM; Sagartz JE; Tong Q; Parker-Thornburg J; Capen CC; Cho JY; Xing S; Ledent C
Endocrinology; 1996 Jan; 137(1):375-8. PubMed ID: 8536638
[TBL] [Abstract][Full Text] [Related]
6. Development of mammary and cutaneous gland tumors in transgenic mice carrying the RET/PTC1 oncogene.
Portella G; Salvatore D; Botti G; Cerrato A; Zhang L; Mineo A; Chiappetta G; Santelli G; Pozzi L; Vecchio G; Fusco A; Santoro M
Oncogene; 1996 Nov; 13(9):2021-6. PubMed ID: 8934550
[TBL] [Abstract][Full Text] [Related]
7. Early cellular abnormalities induced by RET/PTC1 oncogene in thyroid-targeted transgenic mice.
Cho JY; Sagartz JE; Capen CC; Mazzaferri EL; Jhiang SM
Oncogene; 1999 Jun; 18(24):3659-65. PubMed ID: 10380889
[TBL] [Abstract][Full Text] [Related]
8. RET/PTC1 oncogene signaling in PC Cl 3 thyroid cells requires the small GTP-binding protein Rho.
Barone MV; Sepe L; Melillo RM; Mineo A; Santelli G; Monaco C; Castellone MD; Tramontano D; Fusco A; Santoro M
Oncogene; 2001 Oct; 20(48):6973-82. PubMed ID: 11704822
[TBL] [Abstract][Full Text] [Related]
9. The TRK-T1 fusion protein induces neoplastic transformation of thyroid epithelium.
Russell JP; Powell DJ; Cunnane M; Greco A; Portella G; Santoro M; Fusco A; Rothstein JL
Oncogene; 2000 Nov; 19(50):5729-35. PubMed ID: 11126359
[TBL] [Abstract][Full Text] [Related]
10. RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes.
Tallini G; Santoro M; Helie M; Carlomagno F; Salvatore G; Chiappetta G; Carcangiu ML; Fusco A
Clin Cancer Res; 1998 Feb; 4(2):287-94. PubMed ID: 9516913
[TBL] [Abstract][Full Text] [Related]
11. Expression of Ret/PTC1, -2, -3, -delta3 and -4 in German papillary thyroid carcinoma.
Mayr B; Pötter E; Goretzki P; Rüschoff J; Dietmaier W; Hoang-Vu C; Dralle H; Brabant G
Br J Cancer; 1998 Mar; 77(6):903-6. PubMed ID: 9528832
[TBL] [Abstract][Full Text] [Related]
12. Tissue-specific carcinogenesis in transgenic mice expressing the RET proto-oncogene with a multiple endocrine neoplasia type 2A mutation.
Kawai K; Iwashita T; Murakami H; Hiraiwa N; Yoshiki A; Kusakabe M; Ono K; Iida K; Nakayama A; Takahashi M
Cancer Res; 2000 Sep; 60(18):5254-60. PubMed ID: 11016655
[TBL] [Abstract][Full Text] [Related]
13. Loss of p53 promotes anaplasia and local invasion in ret/PTC1-induced thyroid carcinomas.
La Perle KM; Jhiang SM; Capen CC
Am J Pathol; 2000 Aug; 157(2):671-7. PubMed ID: 10934169
[TBL] [Abstract][Full Text] [Related]
14. The roles of phosphotyrosines-294, -404, and -451 in RET/PTC1-induced thyroid tumor formation.
Buckwalter TL; Venkateswaran A; Lavender M; La Perle KM; Cho JY; Robinson ML; Jhiang SM
Oncogene; 2002 Nov; 21(53):8166-72. PubMed ID: 12444552
[TBL] [Abstract][Full Text] [Related]
15. [Radiation-induced thyroid carcinomas in children: high prevalence of RET rearrangement].
Rabes HM; Klugbauer S
Verh Dtsch Ges Pathol; 1997; 81():139-44. PubMed ID: 9474864
[TBL] [Abstract][Full Text] [Related]
16. Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer.
Fusco A; Chiappetta G; Hui P; Garcia-Rostan G; Golden L; Kinder BK; Dillon DA; Giuliano A; Cirafici AM; Santoro M; Rosai J; Tallini G
Am J Pathol; 2002 Jun; 160(6):2157-67. PubMed ID: 12057919
[TBL] [Abstract][Full Text] [Related]
17. Unraveling the pathogenesis of thyroid tumors using transgenic mice.
Tallini G; Costa J
Lab Invest; 1997 Mar; 76(3):301-5. PubMed ID: 9121113
[No Abstract] [Full Text] [Related]
18. Expression of the RET/PTC1 oncogene impairs the activity of TTF-1 and Pax-8 thyroid transcription factors.
De Vita G; Zannini M; Cirafici AM; Melillo RM; Di Lauro R; Fusco A; Santoro M
Cell Growth Differ; 1998 Jan; 9(1):97-103. PubMed ID: 9438393
[TBL] [Abstract][Full Text] [Related]
19. The ret/PTC1 rearrangement is a common feature of Chernobyl-associated papillary thyroid carcinomas from Belarus.
Pisarchik AV; Ermak G; Fomicheva V; Kartel NA; Figge J
Thyroid; 1998 Feb; 8(2):133-9. PubMed ID: 9510121
[TBL] [Abstract][Full Text] [Related]
20. RET receptor expression in thyroid follicular epithelial cell-derived tumors.
Bunone G; Uggeri M; Mondellini P; Pierotti MA; Bongarzone I
Cancer Res; 2000 Jun; 60(11):2845-9. PubMed ID: 10850426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
